Skip to main content
Signal8

Harford Simon N.R.

SEC insider (Form 3/4/5 filer). CIK 0001443705. Chief Financial Officer at AMICUS THERAPEUTICS, INC. (FOLD). 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 27, 2026. Located in PRINCETON, NJ.

Companies Harford Simon N.R. has filed insider reports for

  • AMICUS THERAPEUTICS, INC. (FOLD): Officer, Chief Financial Officer
Harford Simon N.R. profile photo

Harford Simon N.R.

CIK: 0001443705

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AMICUS THERAPEUTICS, INC. logo
FOLD

AMICUS THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • AMICUS THERAPEUTICS, INC. logo
    FOLD

    AMICUS THERAPEUTICS, INC.

    Apr 27, 2026
    Disposition
    Direct
    143.6K shares at avg. $14.50$2.1M
  • AMICUS THERAPEUTICS, INC. logo
    FOLD

    AMICUS THERAPEUTICS, INC.

    Dec 26, 2025
    Tax Payment
    Direct
    71.3K shares at avg. $14.25$1.0M
  • AMICUS THERAPEUTICS, INC. logo
    FOLD

    AMICUS THERAPEUTICS, INC.

    Aug 21, 2025
    Tax Payment
    Direct
    12.5K shares at avg. $7.60$95K
  • AMICUS THERAPEUTICS, INC. logo
    FOLD

    AMICUS THERAPEUTICS, INC.

    Jan 3, 2025
    Award
    Direct
    83.1K shares-
  • AMICUS THERAPEUTICS, INC. logo
    FOLD

    AMICUS THERAPEUTICS, INC.

    Jan 2, 2025
    Tax Payment
    Direct
    7.5K shares at avg. $9.31$70K

1-5 of 5